Intravenous benzotropine mesylate challenge in acute neuroleptic-induced dystonia.
al Jeshi
A
A
al Kaisi
H H
HH
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001590:Benztropine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D009460:Neurologic Examination / Q000187:drug effects; D010276:Parasympatholytics / Q000008:administration & dosage*; D011618:Psychotic Disorders / Q000188:drug therapy*; D014103:Torticollis / Q000139:chemically induced* / Q000188:drug therapy
D014150:Antipsychotic Agents; D010276:Parasympatholytics; D001590:Benztropine; D006220:Haloperidol